[Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
作者信息
Tedeholm Helen, Skoog Bengt, Hillert Jan, Runmarker Björn, Stawiarz Leszek, Oluf Andersen
机构信息
Göteborgs universitet.
出版信息
Lakartidningen. 2007;104(22):1684-8.
PMID:17601317
Abstract
摘要
Zotero 插件